Search

Your search keyword '"Chinnaiyan, Arul"' showing total 3,265 results

Search Constraints

Start Over You searched for: Author "Chinnaiyan, Arul" Remove constraint Author: "Chinnaiyan, Arul"
3,265 results on '"Chinnaiyan, Arul"'

Search Results

1. CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13.

2. A Systematic Overview of Single-Cell Transcriptomics Databases, their Use cases, and Limitations

4. NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis

7. Reply to “Contextualizing racial associations in prostate cancer to expose structural causes”

8. PIKfyve, expressed by CD11c-positive cells, controls tumor immunity

9. Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis

10. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.

11. Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy

12. Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.

14. Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition

16. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations

18. Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance

19. Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies

24. Comprehensive proteogenomic characterization of rare kidney tumors

25. Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer

26. Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas

27. Pan-cancer proteogenomics characterization of tumor immunity

28. Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance

31. Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients—A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT

33. Deep learning integrates histopathology and proteogenomics at a pan-cancer level

34. Proteogenomic insights suggest druggable pathways in endometrial carcinoma

35. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin

36. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

37. Pan-cancer proteogenomics connects oncogenic drivers to functional states

39. Proteogenomic data and resources for pan-cancer analysis

41. Accelerating precision medicine in metastatic prostate cancer

42. The DNA methylation landscape of advanced prostate cancer

43. Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer

44. TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination

47. DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway

48. Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

49. Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer

Catalog

Books, media, physical & digital resources